BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GM101 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of GM101\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07100171-8725@assetmemo.bio
DTSTAMP:20261121T005430Z
DTSTART;VALUE=DATE:20270217
DTEND;VALUE=DATE:20270218
SUMMARY:GM101: Phase 1 readout est. (NCT07100171)
DESCRIPTION:GM101\, phase 1\, Parkinson's Disease.\nStudy: Evaluation of GM
 101 Injection in Patients With Parkinson's Disease\nEstimated primary comp
 letion: 17 February 2027. This is a ClinicalTrials.gov estimate\, not a co
 nfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/
 drug/gm101#upcoming-events\nRegistry record: https://clinicaltrials.gov/st
 udy/NCT07100171
URL:https://assetmemo.bio/drug/gm101#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
